Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring

Hanna de Ruyter,Linnea Aitokari,Siiri Lahti,Hanna Riekki,Heini Huhtala,Timo Lakka,Hannele Laivuori,Kalle Kurppa
DOI: https://doi.org/10.1111/aogs.14816
2024-03-04
Acta Obstetricia Et Gynecologica Scandinavica
Abstract:We studied 460 consecutive children who underwent a healthcare visit due to being overweight or obese and their biological mothers. As a novel finding, we found maternal smoking, gestational hypertension and pre‐eclampsia to be associated with metabolic dysfunction‐associated fatty liver disease in offspring in a multivariate regression model. Introduction Due to a steep increase in obesity, metabolic dysfunction‐associated fatty liver disease (MAFLD) has also become the most common chronic hepatic condition among children and adolescents. Various maternal and pregnancy‐related factors have also been implicated in the development of MAFLD, but human studies remain scarce. Material and methods Comprehensive data of 460 overweight or obese children aged 2–16 years were collected and combined with data on selected maternal and pregnancy‐related factors for a case–control study. MALFD was defined as alanine aminotransferase >2× upper limit of normal. Children with and without MAFLD were compared regarding to the study variables and multivariable regression analysis was utilized. Results Median age of the study children was 11.8 (quartiles 9.1–14.2) years; 44% were girls and 17.8% had MAFLD. Children with MAFLD were older (12.7 vs. 11.6 years, p = 0.002), while the groups did not differ age‐standardized body mass index (BMI‐SDS) or gender. Factors associated with MAFLD in a multivariable model considering also the offspring's present BMI‐SDS, sex, and maternal prepregnancy overweight, were child's older age (odds ratio [OR] 1.16, 95% confidence interval [CI]: 1.06–1.28), maternal gestational smoking (OR 2.01, 95% CI: 1.16–3.47), gestational hypertension (OR 3.44, 95% CI: 1.08–11.0) and pre‐eclampsia (OR 2.93, 95% CI: 1.15–7.45). There was no significant association between MAFLD and maternal BMI, birth anthropometrics or perinatal complications. Conclusions Maternal smoking, gestational hypertension and pre‐eclampsia were associated with MAFLD among overweight or obese children. Further prospective studies are needed to verify causal relationships.
obstetrics & gynecology
What problem does this paper attempt to address?